| Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression. | None |
| Function of the c-Myc oncoprotein in chromatin remodeling and transcription. | None |
| Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc. | None |
| Down-regulation of alpha6 integrin, an anti-oncogene product, by functional cooperation of H-Ras and c-Myc. | None |
| Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2. | None |
| Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. | None |
| Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. | None |
| Expression of the proto-oncogene c-myc in human stenotic aortocoronary bypass grafts. | None |
| In Situ studies demonstrate enhanced mRNA expression of the proto-oncogene c-myc in stenotic venous bypass grafts. | None |
| BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. | None |
| Co-existence of pseudo-Chediak-Higashi anomaly and double minutes containing C-MYC oncogene in three patients with AML M2. | None |
| The myc oncogene: MarvelouslY Complex. | None |
| c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?. | None |
| C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study. | None |
| Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. | None |
| A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc. | None |
| A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with this proto-oncogene protein | None |
| The proto-oncogene c-myc in hematopoietic development and leukemogenesis | None |
| The proto-oncogene c-myc in hematopoietic development and leukemogenesis. | None |
| c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. | None |